quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:11:27·36d
INSIDERFiling
Evaxion A/S logo

SEC Form 3 filed by new insider Evaxion A/S

EVAX· Evaxion A/S
Health Care
Original source

Companies

  • EVAX
    Evaxion A/S
    Health Care

Recent analyst ratings

  • Feb 19UpdateMaxim Group$10.00
  • Apr 2UpdateLadenburg Thalmann$8.00
  • Feb 12UpdateH.C. Wainwright$14.00

Related

  • SEC1d
    SEC Form 6-K filed by Evaxion A/S
  • SEC6d
    SEC Form 6-K filed by Evaxion A/S
  • SEC6d
    SEC Form 6-K filed by Evaxion A/S
  • PR6d
    Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
  • PR6d
    New data demonstrates the unique scalability of Evaxion's AI-Immunology™ platform in glioblastoma
  • SEC7d
    SEC Form 6-K filed by Evaxion A/S
  • PR7d
    Evaxion concludes Annual General Meeting
  • INSIDER13d
    Amendment: SEC Form 3 filed by new insider Mattsson Andreas Holm
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022